JOHN GREGORY JONES MD
Prescription History 1801970421
Emergency Medicine in Greenfield, IN

Active since October 24, 2006PECOS EnrolledAccepts Medicare Assignment
89.55/100
CMS Quality Rating
801 N STATE ST, GREENFIELD, IN 46140(317) 468-4415 Get Directions

NPPES record last updated: January 6, 2023. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOHN GREGORY JONES MD, an active Emergency Medicine specialist practicing in Greenfield, IN. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 268 documented patient claims. Among these therapy options, the most frequently utilized medication is Buprenorphine-Naloxone, which accounts for 255 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
268
Total Claims
273
30-Day Fills
Buprenorphine-Naloxone
Most Prescribed · 255 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by JOHN GREGORY JONES MD in 2024, with prescription volumes, average cost per fill, and IN state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other IN PrescribersVs. IN Avg
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl255$43.89▼ below IN avg▲ More than typical

About Buprenorphine-Naloxone: This medication contains 2 medicines: buprenorphine and naloxone. Show more ▾

It is used to treat opioid use disorder. Buprenorphine belongs to a class of drugs called mixed opioid agonist-antagonists. Buprenorphine helps prevent withdrawal symptoms caused by stopping other opioids. Naloxone is an opioid antagonist that blocks the effect of opioids and can cause severe opioid withdrawal when injected. Withdrawal is less likely when naloxone is taken by mouth, dissolved under the tongue, or dissolved on the inside of the cheek. It is combined with buprenorphine to prevent abuse and misuse (injection) of this medication. This combination medication is used as part of a complete treatment program for opioid use disorder (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). Ask your doctor or pharmacist if you should have naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.

In 2024, this provider wrote 255 Medicare prescriptions for Buprenorphine-Naloxone, about 2.6 times the volume of the typical Indiana prescriber of this medication (97.7). Medicare paid an average of $43.89 per fill, versus $79.16 statewide.

How often this provider prescribes it

This provider
255
IN average
97.7

This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$43.89
IN average
$79.16

This provider's average cost per fill is below the IN average for this medication.

255
30-Day Fills
standardized to 30-day supplies
2,770
Days of Medication
total across all patients in 2024
Brimonidine Tartrate13$19.91▼ below IN avg▼ Less than typical

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2024, this provider wrote 13 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical Indiana prescriber of this medication (58.7). Medicare paid an average of $19.91 per fill, versus $28.65 statewide.

How often this provider prescribes it

This provider
13
IN average
58.7

This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.91
IN average
$28.65

This provider's average cost per fill is below the IN average for this medication.

18
30-Day Fills
standardized to 30-day supplies
540
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average IN prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the IN average cost per fill.

About this data. The prescription history for JOHN GREGORY JONES MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Emergency Medicine prescribing approach at this Greenfield, IN practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.